Development of a novel lentivirus-based suicide gene therapy approach using 
modified human thymidylate monophosphate kinase

Sato, T.; Neschadim, A.; Rasaiah, V.; Konrad, M.; Lavie, A.; Medin, J. A.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Conference Paper

Development of a novel lentivirus-based suicide gene therapy approach using modified human thymidylate monophosphate kinase

MPS-Authors

/persons/resource/persons15362

Konrad, M.
Research Group of Enzyme Biochemistry, MPI for biophysical chemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Sato, T., Neschadim, A., Rasaiah, V., Konrad, M., Lavie, A., & Medin, J. A. (2006). Development of a novel lentivirus-based suicide gene therapy approach using modified human thymidylate monophosphate kinase. Journal of Gene Medicine, 8(3), 399-399.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0012-E529-5

Abstract

There is no abstract available